TNFSF10 and neoplasm: In addition, the short half-life of NSC130262 in the mouse bloodstream suggested that the combination of NSC130362 with also short-lived TRAIL (21) could be ineffective in mice despite their clear synergistic anti-tumor effect in cell-based assays.